GGrantIndex
← Search

94010 PHASE I STUDY OF ORAL BCX 34 IN PATIENTS WITH T CELL MALIGNANCIES

$42,739M01FY2000RRNIH

Tufts Medical Center, Boston MA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →